Many cancers hijack this regulation mechanism and overexpress the enzymes involved in the first step of the KP, indoleamine-2,3-dioxygenase (IDO) and tryptophan-2,3-dioxygenase (TDO), for immune escape [8,9,10,11]. This evidence concerns the gene IDO1 and cancer.